Treatment of Osteoporosis with Vitamin D

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 1997 Jan 1

PMID 9536320

Citations 3

Authors

J A Kanis

E V McCloskey

D de Takats

J Bernard

D M Zhang

Affiliations

Soon will be listed here.

Citing Articles

Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Brandi M Clin Cases Miner Bone Metab. 2012; 7(3):243-50.

PMID: 22460535 PMC: 3213838.

Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Brown S, ONTJES D, Lester G, Lark R, Hensler M, Blackwood A Osteoporos Int. 2003; 14(5):442-9.

PMID: 12774194 DOI: 10.1007/s00198-002-1331-x.

Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.

Osteoporos Int. 1997; 7 Suppl 3:1-222.

PMID: 9565455

References

Aloia J, Vaswani A, Yeh J, Ellis K, Yasumura S, Cohn S . Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med. 1988; 84(3 Pt 1):401-8. DOI: 10.1016/0002-9343(88)90259-8. View

Hamdy N, Kanis J, Beneton M, Brown C, Juttmann J, Jordans J . Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ. 1995; 310(6976):358-63. PMC: 2548761. DOI: 10.1136/bmj.310.6976.358. View

Fonseca V, Mohiuddin J, Weerakoon J, Boss M, Mikhailidis D, Dandona P . Plasma creatinine and creatinine clearance in nutritional osteomalacia. Lancet. 1984; 1(8386):1093-5. DOI: 10.1016/s0140-6736(84)92507-8. View

Orimo H, Shiraki M, Hayashi T, Nakamura T . Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3. Bone Miner. 1987; 3(1):47-52. View

Pouilles J, Tremollieres F, Ribot C . Prevention of post-menopausal bone loss with 1 alpha-hydroxy vitamin D3. A three-year prospective study. Clin Rheumatol. 1992; 11(4):492-7. DOI: 10.1007/BF02283104. View

Naik R, Cundy T, Robinson B, Russell R, Kanis J . Effects of vitamin D metabolites and analogues on renal function. Nephron. 1981; 28(1):17-25. DOI: 10.1159/000182088. View

Ranstam J, Kanis J . Influence of age and body mass on the effects of vitamin D on hip fracture risk. Osteoporos Int. 1995; 5(6):450-4. DOI: 10.1007/BF01626607. View

Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S . Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int. 1994; 54(5):370-6. DOI: 10.1007/BF00305521. View

Lips P . Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest. 1996; 26(6):436-42. DOI: 10.1046/j.1365-2362.1996.176290.x. View

10.

Shiraki M, Orimo H, Ito H, Akiguchi I, NAKAO J, Takahashi R . Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3). Endocrinol Jpn. 1985; 32(2):305-15. DOI: 10.1507/endocrj1954.32.305. View

11.

Gallagher J, Riggs B . Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabolism. 1990; 39(4 Suppl 1):30-4. DOI: 10.1016/0026-0495(90)90269-i. View

12.

Kanis J, McCloskey E, Beneton M . Vitamin D and analogues in renal bone disease and implications for osteoporosis. Osteoporos Int. 1997; 7 Suppl 3:S179-83. DOI: 10.1007/BF03194368. View

13.

Nordin B, Baker M, Horsman A, Peacock M . A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr. 1985; 42(3):470-4. DOI: 10.1093/ajcn/42.3.470. View

14.

Gallagher J, Goldgar D . Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann Intern Med. 1990; 113(9):649-55. DOI: 10.7326/0003-4819-113-9-649. View

15.

Nordin B, Need A, Morris H, Horowitz M, Robertson W . Evidence for a renal calcium leak in postmenopausal women. J Clin Endocrinol Metab. 1991; 72(2):401-7. DOI: 10.1210/jcem-72-2-401. View

16.

Gallagher J, Jerpbak C, Jee W, Johnson K, DeLuca H, Riggs B . 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci U S A. 1982; 79(10):3325-9. PMC: 346408. DOI: 10.1073/pnas.79.10.3325. View

17.

Gallagher J, Riggs B, Recker R, Goldgar D . The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol Med. 1989; 191(3):287-92. DOI: 10.3181/00379727-191-42922. View

18.

CHAPUY M, Arlot M, Delmas P, Meunier P . Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ. 1994; 308(6936):1081-2. PMC: 2539939. DOI: 10.1136/bmj.308.6936.1081. View

19.

Heikinheimo R, Inkovaara J, Harju E, Haavisto M, Kaarela R, Kataja J . Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int. 1992; 51(2):105-10. DOI: 10.1007/BF00298497. View

20.

Hoikka V, Alhava E, Aro A, Karjalainen P, Rehnberg V . Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium. Acta Med Scand. 1980; 207(3):221-4. DOI: 10.1111/j.0954-6820.1980.tb09709.x. View